logoTry Persana

C16 Biosciences - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about C16 Biosciences including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

C16 Biosciences company logo

C16 Biosciences produces high-performance biodesigned ingredients for the personal care, home care, and food industries.

C16 Biosciences uses innovative processes found in nature to brew sustainable alternatives to palm oil, significantly reducing the environmental footprint associated with current palm oil production.

HeadquartersNew York, United States
Team size1-50
Founded2018

What is C16 Biosciences? - Company Overview & Details

C16 Biosciences is C16 Biosciences uses innovative processes found in nature to brew sustainable alternatives to palm oil, significantly reducing the environmental footprint associated with current palm oil production. Founded in 2018, the company is headquartered in New York, United States.

Who Founded C16 Biosciences?

C16 Biosciences was founded by Shara Ticku, David Heller, Harry McNamara.

Who are the Key Executives at C16 Biosciences? - Leadership Team

C16 Biosciences is led by experienced executives in key positions:

Chief Executive Officer (CEO) of C16 Biosciences

Shara TickuCEO

Chief Technology Officer (CTO) of C16 Biosciences

CTO

About Shara Ticku - CEO of C16 Biosciences

Shara Ticku serves as the Chief Executive Officer of C16 Biosciences, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

C16 Biosciences Company Details & Key Information

Where is C16 Biosciences located?

C16 Biosciences is headquartered in New York, United States.

How many employees does C16 Biosciences have?

C16 Biosciences has 1-50 employees.

When was C16 Biosciences founded?

C16 Biosciences was founded in 2018.

C16 Biosciences Official Website

How much funding has C16 Biosciences raised?

C16 Biosciences has raised $30 Million across 6 funding rounds. The most recent funding was completed on 2024-02-24.

Funding Overview

C16 Biosciences has raised a total of $30 million in funding to develop sustainable alternatives to palm oil.

$30 Million
Total Funding Raised
6
Funding Rounds
2024-02-24
Latest Round

C16 Biosciences Funding History

Venture funding
2024-01-30
$1 Million
Grant
2024-01-28
$3.5 Million
Series Unknown
2024-02-24
$1 Million

Who are the key investors in C16 Biosciences?

C16 Biosciences is backed by 3 key investors including Elemental Excelerator, Bill & Melinda Gates Foundation, Breakthrough Energy Ventures. These investors focus on Climate technology, Sustainable solutions, Global health sectors.

C16 Biosciences Investor Overview

3
Key Investors
6
Focus Areas
0
Notable Investments

Complete List of C16 Biosciences Investors

Elemental Excelerator

A nonprofit accelerator focused on climate tech with substantial community impact.

Investment Focus
Climate technology
Sustainable solutions

Bill & Melinda Gates Foundation

Foundation backing initiatives to address global challenges and reduce poverty.

Investment Focus
Global health
Sustainable development

Breakthrough Energy Ventures

Investment firm seeking to support innovative technologies that mitigate climate change.

Investment Focus
Clean energy
Sustainable agriculture

What sectors do C16 Biosciences investors focus on?

The investors backing C16 Biosciences primarily focus on Climate technology, Sustainable solutions, Global health, Sustainable development, Clean energy, Sustainable agriculture sectors.

Climate technology
Sustainable solutions
Global health
Sustainable development
Clean energy
Sustainable agriculture

Featured Investor: Elemental Excelerator

Elemental Excelerator

A nonprofit accelerator focused on climate tech with substantial community impact.

Notable Investments:

What are C16 Biosciences's future plans?

C16 Biosciences C16 Biosciences aims to further develop its Palmless product line and expand its applications in the food industry.

C16 Biosciences Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does C16 Biosciences face?

C16 Biosciences has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for C16 Biosciences

1

Competing against established palm oil production

2

Scaling production capabilities

What opportunities does C16 Biosciences have?

C16 Biosciences has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for C16 Biosciences

1

Growing demand for sustainable products

2

Expansion into new markets such as food

C16 Biosciences Strategic Position Summary

Key Focus Areas

C16 Biosciences is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about C16 Biosciences?

C16 Biosciences has 2 recent news updates covering key business developments and market activities.

C16 Biosciences News Overview

2
Recent Articles
Active
Media Coverage
2025-05-22
Latest Update

What is C16 Biosciences in the news for?

C16 Biosciences is currently featured in news for C16 Biosciences, Inc. launched Palmless oil on May 22nd '25. and other significant business developments.

Recent News Articles About C16 Biosciences

Article 1
2025-05-22

C16 Biosciences, Inc. launched Palmless oil on May 22nd '25.

C16 Biosciences launched its Palmless oil, an environmentally conscious alternative to palm oil.

naturalproductsonline.co.uk
Read News
Article 2
2024-01-29

C16 Biosciences, Inc. receives financing of $1M in Venture funding.

C16 Biosciences, a startup focused on sustainable palm oil alternatives, has secured $1 Million in funding.

alleywatch.com
Read News

C16 Biosciences FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about C16 Biosciences including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

C16 Biosciences Questions & Answers - Company Information

Q1

What is C16 Biosciences?

C16 Biosciences uses innovative processes found in nature to brew sustainable alternatives to palm oil, significantly reducing the environmental footprint associated with current palm oil production.

Q2

Who founded C16 Biosciences?

C16 Biosciences was founded by Shara Ticku, David Heller, Harry McNamara.

Q3

Who is the CEO of C16 Biosciences?

The CEO of C16 Biosciences is Shara Ticku. You can find more information about them on their LinkedIn profile.

Q4

How much funding has C16 Biosciences raised?

C16 Biosciences has raised a total of $$30 Million across 6 funding rounds. The most recent funding was completed on 2024-02-24.

Q5

Who are the investors in C16 Biosciences?

C16 Biosciences's key investors include Elemental Excelerator, Bill & Melinda Gates Foundation, Breakthrough Energy Ventures.

Q6

Where is C16 Biosciences headquartered?

C16 Biosciences is headquartered in New York, United States.

Q7

When was C16 Biosciences founded?

C16 Biosciences was founded in 2018.

Q8

How many employees does C16 Biosciences have?

C16 Biosciences has 1-50 employees.

Q9

What is C16 Biosciences's official website?

You can visit C16 Biosciences's official website at http://www.c16bio.com.

Q10

What was C16 Biosciences's latest funding round?

C16 Biosciences's latest funding round was a Venture funding round of $$1 Million completed on 2024-01-30.

Q11

Who is founder?

Shara Ticku

Q12

What does the company do?

C16 Biosciences develops sustainable alternatives to palm oil using innovative fermentation processes.

Q13

How much funding?

$30 Million

Q14

Latest funding date?

2024-02-24

Q15

Who are the investors?

Elemental Excelerator Bill & Melinda Gates Foundation Breakthrough Energy Ventures

Q16

What are the challenges?

Competing against established palm oil production Scaling production capabilities

Q17

What are the opportunities?

Growing demand for sustainable products Expansion into new markets such as food

Q18

Latest news?

C16 Biosciences launched its Palmless oil, an environmentally conscious alternative to palm oil. C16 Biosciences, a startup focused on sustainable palm oil alternatives, has secured $1 Million in funding.

More Information About C16 Biosciences

For additional details about C16 Biosciences, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.